Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis.
作者信息
Ferini Gianluca, Pergolizzi Stefano
机构信息
REM Radioterapia srl, Viagrande (CT), Italy.
Radiation Oncology Unit - Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy.
出版信息
Clin Transl Radiat Oncol. 2023 Sep 16;43:100679. doi: 10.1016/j.ctro.2023.100679. eCollection 2023 Nov.
Abstract
摘要
相似文献
1
Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis.
Clin Transl Radiat Oncol. 2023 Sep 16;43:100679. doi: 10.1016/j.ctro.2023.100679. eCollection 2023 Nov.
2
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Lancet Oncol. 2015 Mar;16(3):274-83. doi: 10.1016/S1470-2045(14)70482-6. Epub 2015 Feb 3.
3
Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities.
Strahlenther Onkol. 2020 Jul;196(7):598-607. doi: 10.1007/s00066-020-01589-w. Epub 2020 Feb 10.
4
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Lancet Oncol. 2016 Apr;17(4):464-474. doi: 10.1016/S1470-2045(15)00567-7. Epub 2016 Mar 9.
5
How Much Daily Image-guided Volumetric Modulated Arc Therapy Is Useful for Proctitis Prevention With Respect to Static Intensity Modulated Radiotherapy Supported by Topical Medications Among Localized Prostate Cancer Patients?
Anticancer Res. 2021 Apr;41(4):2101-2110. doi: 10.21873/anticanres.14981.
6
Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study.
Pathol Oncol Res. 2020 Apr;26(2):905-912. doi: 10.1007/s12253-019-00623-2. Epub 2019 Mar 19.
7
Prospective Phase II Trial of Once-weekly Hypofractionated Radiation Therapy for Low-risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes.
Clin Oncol (R Coll Radiol). 2016 Jun;28(6):386-92. doi: 10.1016/j.clon.2015.12.024. Epub 2016 Jan 11.
8
Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.
Anticancer Res. 2015 May;35(5):3049-54.
9
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.
Radiother Oncol. 2019 Jun;135:19-24. doi: 10.1016/j.radonc.2019.02.014. Epub 2019 Mar 5.
10
Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost.
Radiat Oncol. 2022 Jan 20;17(1):12. doi: 10.1186/s13014-021-01976-2.
本文引用的文献
1
Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis.
Clin Transl Radiat Oncol. 2023 Mar 17;40:100612. doi: 10.1016/j.ctro.2023.100612. eCollection 2023 May.
2
MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer.
Cancers (Basel). 2021 Apr 9;13(8):1791. doi: 10.3390/cancers13081791.
3
A Ten-year-long Update on Radiation Proctitis Among Prostate Cancer Patients Treated With Curative External Beam Radiotherapy.
In Vivo. 2021 May-Jun;35(3):1379-1391. doi: 10.21873/invivo.12390. Epub 2021 Apr 28.
4
How Much Daily Image-guided Volumetric Modulated Arc Therapy Is Useful for Proctitis Prevention With Respect to Static Intensity Modulated Radiotherapy Supported by Topical Medications Among Localized Prostate Cancer Patients?
Anticancer Res. 2021 Apr;41(4):2101-2110. doi: 10.21873/anticanres.14981.
5
Acute toxicity and quality of life in high risk prostate cancer patients: Updated results of randomized hypofractionation trial.
Rep Pract Oncol Radiother. 2018 Jul-Aug;23(4):284-289. doi: 10.1016/j.rpor.2018.06.008. Epub 2018 Jul 26.
6
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.
Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1420-1429. doi: 10.1016/j.ijrobp.2018.07.2006. Epub 2018 Jul 31.
7
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.
J Clin Oncol. 2017 Jun 10;35(17):1884-1890. doi: 10.1200/JCO.2016.71.7397. Epub 2017 Mar 15.
8
Acute and late toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated pelvic radiation therapy.
Pract Radiat Oncol. 2017 Jul-Aug;7(4):264-269. doi: 10.1016/j.prro.2017.01.003. Epub 2017 Jan 20.
9
Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin.
Radiother Oncol. 2016 Oct;121(1):103-108. doi: 10.1016/j.radonc.2016.07.018. Epub 2016 Aug 28.
10
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol. 2016 Aug;17(8):1047-1060. doi: 10.1016/S1470-2045(16)30102-4. Epub 2016 Jun 20.
Zotero 插件